| abstract |
The problem of the present invention is alopecia, in particular alopecia areata, male alopecia, male alopecia, female alopecia, postpartum alopecia, seborrheic alopecia, nasal alopecia, senile alopecia, cancer chemotherapeutic alopecia, alopecia due to radiation exposure It is effective and safe, and it is effective for those who have treatment resistance to minoxidil or finasteride, and it does not have side effects such as itching, irritation, feminization, no contraindications, suppress dandruff, have a gray hair treatment effect, and discontinue use. It is to provide a new hair loss treatment that does not lose the hair loss treatment effect over the long term. The solution of the present invention is an anti-alopecia therapeutic agent having an active ingredient comprising a type C natriuretic peptide (CNP) or a type B natriuretic peptide (BNP), derivatives of these NPs, chimeric peptides of these NPs, or derivatives of these NPs. . |